BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


SEARCH JOBS










 Company News
Regen BioPharma Makes Three Presentations At The 13th International Symposium On Myelodysplastic Syndromes Held April 29 To May 2, 2015 In Washington, DC 5/6/2015 10:09:34 AM
Regen BioPharma Sees Opportunities Resulting From AACR Conference Attendance And Presentation 4/28/2015 11:08:39 AM
Regen BioPharma Engages Charles River Laboratories To Initiate FDA-Requested Study To Support Initiation Of HemaXellerate Clinical Trial 4/23/2015 11:49:50 AM
Regen BioPharma Recruits Renowned Cancer Stem Cell Experts To Scientific Advisory Board 4/17/2015 11:02:47 AM
Regen BioPharma Narrows Selection Of CRO Candidates For HemaXellerate GLP Safety Studies Requested By The FDA 4/14/2015 12:56:57 PM
Regen BioPharma Announces Small Molecule Drug Discovery Milestones At American Association for Cancer Research's 2015 Annual Meeting 4/9/2015 10:05:32 AM
Regen BioPharma To Present Multiple Presentations At The 13th International Symposium On Myelodysplastic Syndromes 4/7/2015 12:28:54 PM
Regen BioPharma Expands Its Differentiation Therapy of Cancer Stem Cells Platform With Filing Of Patent Applications On Silencing Of NR2F2 4/7/2015 10:17:10 AM
Regen BioPharma CEO Discusses Recent Financings, New Laboratory Facilities And Preferred Stock Dividend 4/3/2015 9:39:40 AM
Regen BioPharma Announces Presentation Of DiffronC At Cold Spring Harbor Conference On RNA & Oligonucleotide Therapeutics 4/3/2015 9:35:25 AM
1234